43061-13-8

Basic information

• Product Name: (R)-2,5-Dimethoxy-4-methylamphetamine
• Synonyms: (R)-1-(2,5-Dimethoxy-4-methylbenzyl)ethanamine;(R)-2,5-Dimethoxy-4-methylamphetamine;(R)-4,α-Dimethyl-2,5-dimethoxybenzeneethanamine;(αR)-2,5-Dimethoxy-α,4-dimethylbenzeneethaneamine
• CAS NO: 43061-13-8
• Molecular Formula: C₁₂H₁₉NO₂
• Molecular Weight: 209.28
• Mol File: 43061-13-8.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (R)-2,5-Dimethoxy-4-methylamphetamine(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-2,5-Dimethoxy-4-methylamphetamine(43061-13-8)
• EPA Substance Registry System: (R)-2,5-Dimethoxy-4-methylamphetamine(43061-13-8)

Safety Data

• Hazardous Substances Data: 43061-13-8(Hazardous Substances Data)

Usage

Description

(R)-2,5-Dimethoxy-4-methylamphetamine, commonly known as DMMA, is a psychoactive drug belonging to the amphetamine class of compounds. It is a derivative of methamphetamine and shares a similar chemical structure with MDMA (ecstasy). DMMA is recognized for its hallucinogenic and stimulant properties, often used recreationally for its psychedelic effects. This drug can induce alterations in perception, mood, and cognition. However, it is also known for its high potential for abuse and addiction. In the United States, DMMA is classified as a Schedule I controlled substance, making it illegal to manufacture, possess, or distribute without proper authorization. The effects of DMMA on the brain and body are not well-researched, and there is limited information on the potential dangers and risks associated with its use.

Uses

Used in Recreational Settings:
DMMA is used as a recreational drug for its hallucinogenic and stimulant effects, providing users with altered perceptions, mood, and cognition. Its psychedelic properties make it a popular choice among those seeking novel experiences.
Used in Research:
Although limited, DMMA may be utilized as a research chemical to study the effects of psychoactive substances on the brain and their potential applications in medicine. This application is typically restricted to controlled laboratory settings and requires proper authorization due to its Schedule I classification.

Upstream product

• 609771-68-8 (2S)-1-(2,5-dimethoxy-4-methylphenyl)-2-propyl azide 
• 15588-95-1 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane 
• 609771-67-7 (2S)-1-(2,5-dimethoxy-4-methylphenyl)-2-propyl tosylate 
• 609771-66-6 (2S)-1-(2',5'-dimethoxy-4'-methylphenyl)-2-propanol 
• 13321-74-9 1-bromo-2,5-dimethoxy-4-methylbenzene 
• 24599-58-4 2,5-dimethoxy toluene 
• 29907-72-0 1-(2,5-Dimethoxy-4-methyl-phenyl)-2-nitro-propen 

Downstream Products

• 51267-05-1 (R)-1-(2,5-dimethoxy-4-methylphenyl)-2-(hydroxyamino)propane hydrochloride 
• 76124-13-5 (R)-1-(2,5-dimethoxy-4-methylphenyl)-2-<(benzoyloxy)amino>propane 

Relevant articles and documents

Stereospecific synthesis of amphetamines

Regioselective addition of aryl lithium to commercially available (S)-(+)-propylene oxide provides the corresponding (S)-aryl-2-propanol. The (R)-amphetamine is obtained by conversion of the alcohol to the tosylate followed by azide displacement and hydrogenation. Mitsunobu conversion of the alcohol to the (R)-bromide followed by azide displacement and hydrogenation affords the (S)-amphetamine.

Asymmetric synthesis of psychotomimetic phenylisopropylamines.

-